Dr. Rajneesh Nath, MD
Claim this profileBanner MD Anderson Cancer Center
Studies Leukemia
Studies Lymphoma
12 reported clinical trials
23 drugs studied
Area of expertise
1Leukemia
CD19 positive
FLT3 positive
CD5 positive
2Lymphoma
CD19 positive
CD5 positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Rajneesh Nath, MD is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
More about Rajneesh Nath, MD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Rajneesh Nath, MD has experience with
- Fludarabine
- Cyclophosphamide
- Idecabtagene Vicleucel
- Lenalidomide
- Iadademstat
- Gilteritinib
Breakdown of trials Rajneesh Nath, MD has run
Leukemia
- JCAR017 for Chronic Leukemia or Lymphoma
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
- A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
Lymphoma
- JCAR017 for Chronic Leukemia or Lymphoma
- AB-205 for Lymphoma
- A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoid Leukemia
- JCAR017 for Chronic Leukemia or Lymphoma
- A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
- PBCAR0191 for Blood Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajneesh Nath, MD specialize in?
Rajneesh Nath, MD focuses on Leukemia and Lymphoma. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are FLT3 positive.
Is Rajneesh Nath, MD currently recruiting for clinical trials?
Yes, Rajneesh Nath, MD is currently recruiting for 6 clinical trials in Gilbert Arizona. If you're interested in participating, you should apply.
Are there any treatments that Rajneesh Nath, MD has studied deeply?
Yes, Rajneesh Nath, MD has studied treatments such as Fludarabine, Cyclophosphamide, Idecabtagene Vicleucel.
What is the best way to schedule an appointment with Rajneesh Nath, MD?
Apply for one of the trials that Rajneesh Nath, MD is conducting.
What is the office address of Rajneesh Nath, MD?
The office of Rajneesh Nath, MD is located at: Banner MD Anderson Cancer Center, Gilbert, Arizona 85234 United States. This is the address for their practice at the Banner MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.